Document:

Exhibit 10.1

 

SECURITIES
PURCHASE AGREEMENT

 

THIS
SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of February ___, 2019, by and between Jerrick
Media Holdings, Inc., a Nevada corporation with its headquarters located at 2050 Center Avenue, Suite 640, Fort Lee, NJ 07024
(the “Company”), and the investors identified on the signature page hereto (the “Purchasers”).

 

WHEREAS,
the Company deems it in the best interests of the Company and its stockholders to conduct a private placement offering consisting
of convertible notes and warrants up to the principal aggregate amount of up to $2,500,000 (the “Offering”);

 

WHEREAS,
the Company and Purchasers are executing and delivering this Agreement in reliance upon an exemption from securities registration
afforded by the provisions of Section 4(a)(2) and/or Regulation D (“Regulation D”) promulgated by the United
States Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Securities
Act”); and

 

WHEREAS,
the parties hereto desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell
to Purchasers, and Purchasers shall purchase, (i) a 10% Convertible Promissory Note in the form of Exhibit A hereto (the
“Note”, collectively the “Notes”) in the aggregate principal amount set forth on the signature
page hereto (the “Subscription Amount”) and (ii) a warrant in the form of Exhibit B permitting the Purchasers
to purchase that certain amount of common stock, par value $0.001 per share, of the Company (the “Common Stock”)
equal to 33% of the number of shares of Common Stock underlying the Note on the date of issuance of the Note and as set forth
on the signature page hereto, subject to the terms and conditions therein contained (the “Warrant”, collectively
the “Warrants”, and together with the Notes, the “Securities”).

 

NOW,
THEREFORE, in consideration of the mutual covenants and other agreements contained in this Agreement, the Company and Purchasers
hereby agree as follows:

 

1.  Purchase
and Sale. Upon the terms and subject to the conditions set forth in this Agreement, the Company hereby agrees to (i) sell,
assign, transfer and deliver to Purchasers, and Purchasers hereby agrees to purchase and accept delivery from the Company, the
Notes free of all liens, pledges, mortgages, security interests, charges, restrictions, adverse claims or other encumbrances of
any kind or nature whatsoever (“Encumbrances”), for the consideration specified herein; and (ii) in consideration
of the Note Price delivered by the Purchasers to the Company, the Company hereby agrees to issue the Warrants to the Purchasers
upon receipt of payment for the Notes.

 

(a)
On or before March 11, 2019 (the “First Closing Date”), each Purchaser shall deliver to the Escrow Agent
(as defined below) such Purchaser’s funds in the amount equal to one half the Subscription Amount (the “Initial
Tranche”), and the Company shall deliver to each Purchaser its respective Note and Warrant representing the Initial
Tranche amount. The first closing of the purchase and sale of the Securities pursuant to this Agreement (the “First Closing”)
shall occur at the offices of Lucosky Brookman LLP (the “Escrow Agent”) or such other location as the parties
shall mutually agree. Notwithstanding anything herein to the contrary, the First Closing shall occur on or before March 11,
2019 (the “Termination Date”). With respect to any Closing not held on or before the Termination Date, the
Escrow Agent shall cause (i) all subscription documents executed by the Company or a Purchaser to be returned to the Company or
such Purchaser, as applicable, and (ii) each Initial Tranche to be returned, without interest or deduction to the Purchaser who
delivered such Initial Tranche.

 

(b)
On or before April 22, 2019 each Purchaser shall deliver to the Escrow Agent such Purchaser’s funds in the amount equal
to one half the Subscription Amount (the “Second Tranche”). Upon certain milestones being achieved by the Company
further described below (the “Milestones”), the Company shall consummate a second closing of the purchase and
sale of the Securities pursuant to this Agreement (the “Second Closing”) on which date (the “Second
Closing Date”) the Company shall deliver to each Purchaser its respective Note and Warrant representing the Second Tranche
amount. The Second Closing shall occur at the offices of the Escrow Agent or such other location as the parties shall mutually
agree. Notwithstanding anything herein to the contrary, the Second Closing shall not occur on or before April 21, 2019.

 

     

     

    

 

(c)
The “Milestones” shall mean (i) that the Company having averaged a daily increase of at least 600 content creator
accounts on the Company’s proprietary long-form social publishing platform “Vocal”, based upon a 60 day period
commencing March 11, 2019 and ending on April 22, 2019; and (ii) the Company shall have either (a) generated a minimum amount
of $100,000 in revenue during the Company’s first fiscal quarter of 2019 or (b) generated a minimum amount of $100,000 in
revenue at some later date based upon a 90 day period commencing after January 1, 2019 and ending on such date that the Company
generated a minimum amount of $100,000 in revenue. The Company’s external accountants (not independent auditors) shall verify
the amount the Company has generated in revenues. Furthermore, these revenues referenced in this Section 1(c) shall be related
to Vocal, but need not be generated directly by Vocal. Additionally, no single client shall represent greater than 50% of the
total revenues for the 90 day period.

 

2.  Purchasers
Representations and Warranties. Each Purchaser, for itself and for no other Purchaser, hereby acknowledges, represents and
warrants as follows (with the understanding that the Company will rely on such representations and warranties in determining,
among other matters, the suitability of this investment for the Purchasers in order to comply with federal and state securities
laws):

 

(a)  The
Purchaser has read this Agreement. The Purchaser acknowledges that this Securities Purchase Agreement is not intended to set
forth all of the information which might be deemed pertinent by an investor who is considering an investment in the Securities.
It is the responsibility of the Purchaser (i) to determine what additional information he desires to obtain in evaluating this
investment, and (ii) to obtain such information from the Company;

 

(b)  Standing
of Purchaser. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by this Agreement
and Warrant and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement
and performance by such Purchaser of the transactions contemplated by this Agreement have been duly authorized by all necessary
corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. The Purchaser
has full power and authority to enter into this Agreement, Note and Warrant (each a “Transaction Document”).
Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser
in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against
it in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium fraudulent conveyance, and any other laws of general application affecting enforcement of creditors’
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law;

 

(c)  Authorization
and Power. Purchaser has the requisite power and authority to enter into and perform this Agreement and to purchase the Notes
and accept the Warrants. The execution, delivery and performance of this Agreement by Purchaser and, if Purchaser is an entity,
the consummation by Purchaser of the transactions contemplated hereby have been duly authorized by all necessary company action,
and no further consent or authorization of Purchaser, its board of directors or similar governing body, or stockholders is required,
as applicable. This Agreement has been duly authorized, executed and delivered by Purchaser and constitutes, or shall constitute
when executed and delivered, a valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with the
terms thereof;

 

(d)  No
Conflicts. If Purchaser is an entity, the execution, delivery and performance of this Agreement and the consummation by Purchaser
of the transactions contemplated hereby do not and will not result in a violation of Purchaser’s charter documents, bylaws
or other organizational documents, as applicable;

 

    2

     

    

 

(e)
Own Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to the Company,
which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms such Purchaser understands that the
Securities are “restricted securities” and have not been registered under the Securities Act or any applicable state
securities law and is acquiring the Securities as principal for Purchaser’s own account, for investment only, and not with
a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable
state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any
applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute
or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this
representation and warranty not limiting such Purchaser’s right to sell the Securities otherwise in compliance with applicable
federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business;

 

(f)  Information
on Purchasers. Such Purchaser is an “accredited investor,” as such term is defined in Rule 501(a) of Regulation
D promulgated by the SEC under the Securities Act, is experienced in investments and business matters, has made investments of
a speculative nature and has purchased securities of United States publicly-owned companies in private placements in the past
and, with its representatives, has such knowledge and experience in financial, tax and other business matters as to enable Purchaser
to utilize the information made available by the Company to evaluate the merits and risks of and to make an informed investment
decision with respect to the proposed purchase, which represents a speculative investment. Purchaser is able to bear the risk
of such investment for an indefinite period and to afford a complete loss thereof. Such Purchaser, either alone or together with
its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of
evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of
such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time,
is able to afford a complete loss of such investment. The information in any documents delivered by the Purchaser in connection
with this Agreement, including, but not limited to the Purchaser Questionnaire, is true, correct and complete in all respects
as of the date hereof. The Purchaser agrees promptly to notify the Company in writing of any change in such information after
the date hereof. Purchasers is not required to be registered as a broker-dealer under Section 15 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”);

  

(g)  Compliance
with Securities Act. Purchaser understands and agrees that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities laws by reason of their issuance in a transaction
that does not require registration under the Securities Act, and that such Securities must be held indefinitely unless a subsequent
disposition is registered under the Securities Act or any applicable state securities laws or is exempt from such registration;

 

(h)  Restricted
Securities. The Purchaser understands that the offering of the Securities has not been registered under the Securities Act,
in reliance on an exemption for private offerings provided pursuant to Section 4(a)(2) of the Securities Act and that, as a result,
the Securities will be “restricted securities” as that term is defined in Rule 144 under the Securities Act and, accordingly,
under Rule 144 as currently in effect, that the Securities must be held for at least one (1) year after the investment has been
made (or indefinitely if the Purchasers is deemed an “affiliate” within the meaning of such rule) unless the Securities
is subsequently registered under the Securities Act and qualified under any other applicable securities law or exemptions from
such registration and qualification are available. The Purchasers further understands that the offering of the Securities has
not been qualified or registered under any foreign or state securities laws in reliance upon the representations made and information
furnished by the Purchaser herein and any other documents delivered by the Purchasers in connection with this Agreement; that
the offering has not been reviewed by the SEC or by any foreign or state securities authorities; that the Purchaser’s rights
to transfer the Securities will be restricted, which includes restrictions against transfers unless the transfer is not in violation
of the Securities Act and applicable state securities laws (including investor suitability standards); and that the Company may
in its sole discretion require the Purchasers to provide at Purchaser’s own expense an opinion of its counsel to the effect
that any proposed transfer is not in violation of the Securities Act or any state securities laws;

 

(i)  Legends.
The Purchaser understands and agrees that the Company will cause any necessary legends in addition to representations to be placed
upon any instruments(s) evidencing ownership of the Securities, together with any other legend that may be required by federal
or state securities laws or deemed necessary or desirable by the Company;

 

(j)  Communication
of Offer. Purchaser has a preexisting personal or business relationship with the Company or one or more of its directors,
officers or control persons, and the offer to sell the Securities was directly communicated to Purchaser by the Company. At no
time was Purchaser presented with or solicited by any leaflet, newspaper or magazine article, radio or television advertisement,
or any other form of general advertising or solicited or invited to attend a promotional meeting otherwise than in connection
and concurrently with such communicated offer;

 

    3

     

    

 

(k)  No
Governmental Endorsement. Purchaser understands that no United States federal or state agency or any other governmental or
state agency has passed on or made recommendations or endorsement of the Securities or the suitability of the investment in the
Securities, nor have such authorities passed upon or endorsed the merits of the offering of the Securities;

 

(l)  Receipt
of Information. Purchaser believes it has received all the information it considers necessary or appropriate for deciding
whether to purchase the Securities. Purchaser further represents that through its representatives it has had an opportunity to
ask questions and receive answers from the Company regarding the terms and conditions of the offering of the Securities and the
business, properties and financial condition of the Company and to obtain additional information (to the extent the Company possessed
such information or could acquire it without unreasonable effort or expense) necessary to verify the accuracy of any information
furnished to it or to which it had access; and

 

(m)  No
Market Manipulation. Purchasers and Purchaser’s affiliates have not taken, and will not take, directly or indirectly,
any action designed to, or that might reasonably be expected to, cause or result in stabilization or manipulation of the price
of the Common Stock, to facilitate the sale or resale of the Securities or affect the price at which the Securities may be issued
or resold.

 

(n)
Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser
has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed
any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that
such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting
forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. “Short
Sales” shall have the meaning as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to
include locating and/or borrowing shares of Common Stock). Notwithstanding the foregoing, in the case of a Purchaser that is a
multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other
portions of such Purchaser’s assets, the representation set forth above shall only apply with respect to the portion of
assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.
Other than to other Persons party to this Agreement or to such Purchaser’s representatives, including, without limitation,
its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the
confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction).
Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in
the future.

 

3.  Company
Representations and Warranties. The Company represents and warrants to, and agrees with, Purchaser that:

 

(a)  Due
Incorporation. The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the
jurisdiction of its incorporation;

 

(b)  Authority;
Enforceability. This Agreement has been duly authorized, executed and delivered by the Company and is the valid and binding
agreement of the Company, enforceable in accordance with their terms, except as may be limited by bankruptcy, insolvency, moratorium
or other similar laws affecting the enforcement of creditors’ rights generally, or principles of equity. The Company has
full corporate power and authority necessary to enter into and deliver this Agreement and to perform its obligations thereunder;

 

    4

     

    

 

(c)  Capitalization
and Additional Issuances. The Company has authorized 320 million (320,000,000) shares of which 300 million is Common Stock
and 20 million is preferred stock. As of the date hereof, there are 97,856,646 shares of the Common Stock issued and outstanding
and 128,479,359 shares of the Common Stock which may be issued hereafter in respect of stock options, warrants, convertible securities,
preferred stock or other Company Securities (as defined below) issued or outstanding as of the date hereof. All of the outstanding
shares of the Common Stock are, and the Common Stock to be issued pursuant to the Note and Warrant will be, duly authorized and
validly issued, fully paid and non-assessable and are not (and will not be) subject to preemptive or similar rights affecting
the Common Stock. As of the date hereof, except as described on Schedule 3(c) hereto, there are no (i) contracts to which the
Company is a party obligating the Company to accelerate the vesting of any company equity award as a result of the transactions
contemplated by this Agreement (whether alone or upon the occurrence of any additional or subsequent events), (ii) outstanding
securities of the Company convertible into or exchangeable for shares of the Common Stock, (iii) outstanding options, warrants
or other agreements or commitments to acquire from the Company, or obligations of the Company to issue, shares of capital stock
of (or securities convertible into or exchangeable for shares of capital stock of) the Company, or (iv) restricted shares, restricted
stock units, stock appreciation rights, performance shares, profit participation rights, contingent value rights, “phantom”
stock or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the
value or price of, any shares of capital stock of the Company, in each case that have been issued by the Company (the items in
clauses (i), (ii) and (iii), together with the capital stock of the Company, being referred to collectively as “Company
Securities”). There are no outstanding contracts requiring the Company to repurchase, redeem or otherwise acquire any
Company Securities and the Company is not a party to any voting agreement with respect to any Company Securities;

 

(d)  SEC
Filings; Financial Statements; Absence of Undisclosed Liabilities.

 

(i)  SEC
Filings. The Company has filed with the SEC all registration statements, prospectuses, reports, schedules, forms, statements
and other documents (including exhibits and all other information incorporated by reference) required to be filed or furnished
by it with the SEC since February 5, 2016 (the “Company SEC Documents”) and such Company SEC Documents when
filed were true, correct and complete in all material respects. As of their respective filing dates (or, if amended or superseded
by a subsequent filing, as of the date of the last such amendment or superseding filing prior to the date hereof), each of the
Company SEC Documents complied in all material respects with the applicable requirements of the Sarbanes-Oxley Act of 2002 (including
the rules and regulations promulgated thereunder) and the Exchange Act, and the rules and regulations of the SEC thereunder applicable
to such Company SEC Documents and did not, at the time it was filed (or, if amended, at the time (and taking into account the
content) of such amendment), contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not
misleading. The Company has made available to Purchasers correct and complete copies of all correspondence between the SEC, on
the one hand, and the Company and any of its subsidiaries, on the other hand, occurring since February 5, 2016 and prior to the
date hereof. As of the date hereof, none of the Company SEC Documents is the subject of ongoing SEC review, outstanding SEC comment
or outstanding SEC investigation;

  

(ii)  Financial
Statements. Each of the consolidated financial statements (including, in each case, any related notes thereto) contained in
the Company SEC Documents: (i) complied as to form in all material respects with the published rules and regulations of the SEC
with respect thereto as of their respective dates; (ii) was prepared in accordance with United States generally accepted accounting
principles (“GAAP”) applied on a consistent basis throughout the periods involved (except as may be indicated
in the notes thereto and, in the case of unaudited interim financial statements, as may be permitted by the SEC for Quarterly
Reports on Form 10-Q); and (iii) fairly presented in all material respects the consolidated financial position of the Company
at the respective dates thereof and the consolidated results of the Company’s operations and cash flows for the periods
indicated therein, subject, in the case of unaudited interim financial statements, to normal and year-end audit adjustments as
permitted by GAAP and the applicable rules and regulations of the SEC. As of the date hereof, Rosenberg Rich Baker Berman P.A.
has not resigned or been dismissed as independent public accountants of the Company as a result of or in connection with any disagreements
with the Company on a matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure;

 

(iii)  No
Undisclosed Liabilities. Neither the Company nor any of its subsidiaries has any liability, indebtedness or obligation of
any kind (whether accrued, absolute, contingent, matured, unmatured or otherwise, and whether or not required to be recorded or
reflected on a balance sheet under GAAP) (“Liability”) except for Liabilities that (a) are reflected or recorded
on the Company’s most recent balance sheet included in the Company SEC Documents (including in the notes thereto but only
to the extent it is reasonably apparent that the disclosure in such notes is of a Liability required to be reflected on a balance
sheet prepared in accordance with GAAP) contained in the Company SEC Documents or (b) are current Liabilities (within the meaning
of GAAP) which were incurred since the date of such balance sheet in the ordinary course of business consistent with past practice;

 

    5

     

    

 

(e)  
Related Party Transactions. All contracts, transactions, arrangements and understandings with any executive officer or
director of the Company or any of its subsidiaries, any other person that directly or indirectly controls, is controlled by or
is under common control with (“Affiliate”), the Company, or any person owning 5% or more of the shares of the
Common Stock (or any of such person’s immediate family members or Affiliates or associates), which is required to be disclosed
under Item 404 of Regulation S-K promulgated under the Securities Act, have been fully and properly disclosed in the appropriate
Company SEC Documents. To the Company’s knowledge there are no such contracts, transactions, arrangements or understandings
which have not been so disclosed;

 

(f)  Consents.
No consent, approval, authorization or order of any court, governmental agency or body having jurisdiction over the Company or
of any other person is required for the execution by the Company of this Agreement and compliance and performance by the Company
of its obligations hereunder, including, without limitation, the issuance of Shares and Warrant and sale of the Shares;

 

(g)  No
Violation or Conflict. Neither the issuance of the Warrant nor the issuance and sale of the Shares nor the performance of
the Company’s obligations under this Agreement will:

 

(i)  violate,
conflict with, result in a breach of, or constitute a default (or an event which with the giving of notice or the lapse of time
or both would be reasonably likely to constitute a default) under (a) the charter or bylaws of the Company or (b) any decree,
judgment, order or determination applicable to the Company of any court, governmental agency or body having jurisdiction over
the Company or over the properties or assets of the Company; or

 

(ii)  result
in the creation or imposition of any lien, charge or encumbrance upon the Securities except in favor of Purchasers as described
herein;

 

(h)  Litigation.
There is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or investigation before or by any
court, governmental agency or body having jurisdiction over the Company including, without limitation, any such that would affect
the execution by the Company or the complete and timely performance by the Company of its obligations under this Agreement. The
Company has not, since February 5, 2016, been a party to any material litigation, arbitration or other proceeding, other than
what has been previously disclosed by the Company in the Company SEC Documents;

 

(i)  No
General Solicitation. Neither the Company, nor any of its affiliates, nor any person or entity acting on its or their behalf,
has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities
Act) in connection with the offer or sale of the Shares;

 

(j)  Investment
Company. The Company is not an “investment company” within the meaning of the Investment Company Act of 1940,
as amended;

 

(k)  Listing
and Maintenance Requirements. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with the listing and maintenance requirements for continued listing or quotation of the Company Common Stock
on the trading market on which the Company Common Stock is currently listed or quoted. The issuance and sale of the Shares under
this Agreement does not contravene the rules and regulations of the trading market on which the Company Common Stock is currently
listed or quoted, and no approval of the stockholders of the Company is required for the Company to issue and deliver to the Purchasers
the Shares contemplated by this Agreement;

 

(l)  Full
Disclosure. No representation or warranty or other statement made by the Company in this Agreement in connection with the
contemplated transactions contains any untrue statement of material fact or omits to state a material fact necessary to make the
representations and warranties set forth herein, in light of the circumstances in which they were made, not misleading; and

 

    6

     

    

 

(m)
No Defaults. Except as described on Schedule 3(m) or the SEC Documents, no material default exists in the due performance
and observance of any term, covenant or condition of any permit, license, contract, indenture, mortgage, deed of trust, note,
loan or credit agreement, or any other agreement or instrument evidencing an obligation for borrowed money, or any other agreement
or instrument to which the Company is a party or by which the Company may be bound or to which any of the properties or assets
of the Company is subject the effect of which would have a Material Adverse Effect. Except as described SEC filings, the Company
is not in violation of any material term or provision of its Certificate of Incorporation or By-Laws or in material violation
of any franchise, license, permit, applicable law, rule, regulation, judgment or decree of any governmental agency or court, domestic
or foreign, having jurisdiction over the Company or any of its properties or business.

 

4.
Other Agreements of the Parties.

 

(a)
Participation in Future Financing.

 

(i)
From the date hereof until the date that is the 12 month anniversary of the First Closing Date, upon any issuance by the Company
of its securities for cash consideration, indebtedness or a combination of units thereof (a “Subsequent Financing”),
each Purchaser shall have the right to participate in up to on a pro rata basis of his Subscription Amount on the same terms,
conditions and price provided for in the Subsequent Financing. For example, if Purchaser A invested $500,000 of the total funded
amount of $1,500,000 in this Offering, Purchaser A will have a right to participate in the Qualified Offering (as defined in the
Note) in the amount of up to 33% of the other Purchasers in this Offering.

 

(ii)
At least five (5) business days prior to the closing of the Subsequent Financing, the Company shall deliver to each Purchaser
a written notice of its intention to effect a Subsequent Financing (“Pre-Notice”), which Pre-Notice shall ask
such Purchaser if it wants to review the details of such financing (such additional notice, a “Subsequent Financing Notice”).
Upon the request of a Purchaser, and only upon a request by such Purchaser, for a Subsequent Financing Notice, the Company shall
promptly, but no later than one (1) business day after such request, deliver a Subsequent Financing Notice to such Purchaser.
The Subsequent Financing Notice shall describe in reasonable detail the proposed terms of such Subsequent Financing, the amount
of proceeds intended to be raised thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed
to be effected and shall include a term sheet or similar document relating thereto as an attachment.

 

(iii)
Any Purchaser desiring to participate in such Subsequent Financing must provide written notice to the Company by no later than
5:30 p.m. (New York City time) on the fifth (5th) business day after all of the Purchasers have received the Pre-Notice that such
Purchaser is willing to participate in the Subsequent Financing, the amount of such Purchaser’s participation, and representing
and warranting that such Purchaser has such funds ready, willing, and available for investment on the terms set forth in the Subsequent
Financing Notice. If the Company receives no such notice from a Purchaser as of such fifth (5th) business day, such Purchaser
shall be deemed to have notified the Company that it does not elect to participate.

 

(iv)
If by 5:30 p.m. (New York City time) on the fifth (5th) business day after all of the Purchasers have received the Pre-Notice,
notifications by the Purchasers of their willingness to participate in the Subsequent Financing (or to cause their designees to
participate) is, in the aggregate, less than the total amount of the Subsequent Financing, then the Company may effect the remaining
portion of such Subsequent Financing on the terms and with the Persons set forth in the Subsequent Financing Notice.

 

(v)
If by 5:30 p.m. (New York City time) on the fifth (5th) business day after all of the Purchasers have received the Pre-Notice,
the Company receives responses to a Subsequent Financing Notice from Purchasers seeking to purchase more than the aggregate amount
of the Participation Maximum, each such Purchaser shall have the right to purchase its Pro Rata Portion (as defined below) of
the Participation Maximum. “Pro Rata Portion” means the ratio of (x) the Subscription Amount of Securities purchased
on the Closing Date by a Purchaser participating under this Section 4 and (y) the sum of the aggregate Subscription Amounts of
Securities purchased on the Second Closing Date by all Purchasers participating under this Section 4.

 

    7

     

    

 

(vi)
The Company must provide the Purchasers with a second Subsequent Financing Notice, and the Purchasers will again have the right
of participation set forth above in this Section 4, if the Subsequent Financing subject to the initial Subsequent Financing Notice
is not consummated for any reason on the terms set forth in such Subsequent Financing Notice within thirty (30) business days
after the date of the initial Subsequent Financing Notice.

 

(vii)
The Company and each Purchaser agree that if any Purchaser elects to participate in the Subsequent Financing, the transaction
documents related to the Subsequent Financing shall not include any term or provision whereby such Purchaser shall be required
to agree to any restrictions on trading as to any of the Securities purchased hereunder or be required to consent to any amendment
to or termination of, or grant any waiver, release or the like under or in connection with, this Agreement, without the prior
written consent of such. In addition, the Company and each Purchaser agree that, in connection with a Subsequent Financing, the
transaction documents related to the Subsequent Financing shall include a requirement for the Company to issue a widely disseminated
press release by 9:30 am (New York City time) on the business day of execution of the transaction documents in such Subsequent
Financing (or, if the date of execution is not a business day, on the immediately following business day) that discloses the material
terms of the transactions contemplated by the transaction documents in such Subsequent Financing.

 

(viii)
Notwithstanding anything to the contrary in this Section 4 and unless otherwise agreed to by such Purchaser, the Company shall
either confirm in writing to such Purchaser that the transaction with respect to the Subsequent Financing has been abandoned or
shall publicly disclose its intention to issue the securities in the Subsequent Financing, in either case in such a manner such
that such Purchaser will not be in possession of any material, non-public information, by the tenth (10th) business day following
delivery of the Subsequent Financing Notice. If by such tenth (10th) business day, no public disclosure regarding a transaction
with respect to the Subsequent Financing has been made, and no notice regarding the abandonment of such transaction has been received
by such Purchaser, such transaction shall be deemed to have been abandoned and such Purchaser shall not be deemed to be in possession
of any material, non-public information with respect to the Company or any of its subsidiaries.

 

(ix)
Notwithstanding the foregoing, this Section 4 shall not apply in respect of offering of the Company’s securities in the
amount less than $500,000.

 

(b)

 

5.
Adjustments for Stock Splits. In the event and to the extent that the Company consummates a reverse stock split or forward
stock split prior to the closing of this transaction, the number of issuable shares of Common Stock purchased under this agreement,
including the shares underlying the Note and the shares of Common Stock issuable pursuant to the Warrant shall be proportionately
and equitably adjusted.

 

6.  Broker’s
Commission/Finder’s Fee. The Company has not yet incurred any obligation for any finder’s, broker’s or agent’s
fees or commissions in connection with the transaction contemplated hereby. The Company, may however, incur obligations for any
registered broker’s or agent’s fees or commissions in connection with the transaction contemplated hereby.

 

7.  Covenants
Regarding Indemnification. Each party hereto agrees to indemnify, hold harmless, reimburse and defend the other party and
the other party’s officers, directors, agents, counsel, affiliates, members, managers, control persons, and principal shareholders,
as applicable, against any claim, cost, expense, liability, obligation, loss or damage (including reasonable legal fees) of any
nature, incurred by or imposed upon the indemnified party or any such person which results, arises out of or is based upon (i)
any breach of any representation or warranty by the indemnifying party in this Agreement or (ii) any breach or default in performance
by the indemnifying party of any covenant or undertaking to be performed by the indemnifying party.

 

8.  Intellectual
Property Rights. The Company and its subsidiaries own or possess adequate rights or licenses to use all trademarks, trade
names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and rights necessary to conduct their respective businesses as now conducted. The Company
and its subsidiaries do not have any knowledge of any infringement by the Company or its subsidiaries of trademark, trade name
rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations, trade
secret or other similar rights of others, or of any such development of similar or identical trade secrets or technical information
by others and, except as set forth on Schedule 3(n), there is no claim, action or proceeding being made or brought against, or
to the Company’s knowledge, being threatened against, the Company or its subsidiaries regarding trademarks, trade name rights,
patents, patent rights, inventions, copyrights, licenses, service names, service marks, service mark registrations, trade secrets
or other.

 

    8

     

    

 

9.  Foreign
Corrupt Practices Act. To the Company’s knowledge, neither the Company, nor any director, officer, agent, employee or
other person acting on behalf of the Company or any subsidiary has, in the course of acting for, or on behalf of, the Company,
directly or indirectly used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses
relating to political activity; directly or indirectly made any direct or indirect unlawful payment to any foreign or domestic
government official or employee from corporate funds; violated or is in violation of any provision of the U.S. Foreign Corrupt
Practices Act of 1977, as amended, or any similar treaties of the United States; or directly or indirectly made any bribe, rebate,
payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government or party official or employee.

 

10.  Miscellaneous.

 

(a)  Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery or facsimile, addressed as set forth on the signature pages hereto or to such other address as such party shall
have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder
shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting
facsimile machine, at the address or number designated on the signature page hereto (if delivered on a business day during normal
business hours where such notice is to be received), or the first business day following such delivery (if delivered other than
on a business day during normal business hours where such notice is to be received) or (b) on the second business day following
the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing,
whichever shall first occur.

 

(b)  Counterparts/Execution.
This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate counterparts,
each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one and the same
instrument. This Agreement may be executed by facsimile transmission, PDF, electronic signature or other similar electronic means
with the same force and effect as if such signature page were an original thereof.

 

(c)  Law
Governing this Agreement. This Agreement shall be governed by and construed in accordance with the laws of the State of New
Jersey without regard to principles of conflicts of laws. Any action brought by either party hereto against the other concerning
the transactions contemplated by this Agreement shall be brought only in the state courts of New Jersey or in the federal courts
located in the state of New Jersey. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue
of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum
non conveniens. The parties hereto agree to submit to the in personam jurisdiction of such courts and hereby irrevocably waive
trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and
costs.

 

(d)  Severability.
In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party
hereto hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any other manner permitted by law.

 

    9

     

    

 

(e)
Fees and Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the
fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party
incident to the negotiation, preparation, execution, delivery and performance of this Agreement upon the First Closing Date. The
Company shall pay its counsel, Lucosky Brookman LLP, for services rendered in connection with this Offering and preparation of
the Transaction Documents, a rate billable on an hourly basis. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to
the Purchasers.

 

(f)  Captions.
The captions of the various sections and paragraphs of this Agreement have been inserted only for the purposes of convenience;
such captions are not a part of this Agreement and shall not be deemed in any manner to modify, explain, enlarge or restrict any
of the provisions of this Agreement.

 

(g)  Confidentiality.
The Purchaser covenants and agrees that it will keep confidential and will not disclose or divulge any confidential or proprietary
information that such Purchaser may obtain from the Company pursuant to financial statements, reports, and other materials submitted
by the Company to such Purchaser in connection with this Offering or as a result of discussions with or inquiry made to the Company,
unless such information is known, or until such information becomes known, to the public through no action by the Purchaser; provided,
however, that a Purchaser may disclose such information to its attorneys, accountants, consultants, and other professionals to
the extent necessary in connection with his or her investment in the Company so long as any such professional to whom such information
is disclosed is made aware of the Purchaser’s obligations hereunder and such professional agrees to be likewise bound as
though such professional were a party hereto.

 

(h)  Entire
Agreement. This Securities Purchase Agreement (including the Exhibits attached hereto) and other Offering documents delivered
at the closing pursuant hereto, contain the entire understanding of the parties in respect of its subject matter and supersedes
all prior agreements and understandings between or among the parties with respect to such subject matter. The Exhibits constitute
a part hereof as though set forth in full above.

 

(i)  Amendment;
Waiver. This Securities Purchase Agreement may not be modified, amended, supplemented, canceled or discharged, except by written
instrument executed by both parties. No failure to exercise and no delay in exercising, any right, power or privilege under this
Securities Purchase Agreement shall operate as a waiver, nor shall any single or partial exercise of any right, power or privilege
hereunder preclude the exercise of any other right, power or privilege. No waiver of any breach of any provision shall be deemed
to be a waiver of any proceeding or succeeding breach of the same or any other provision, nor shall any waiver be implied from
any course of dealing between the parties. No extension of time for performance of any obligations or other acts hereunder or
under any other agreement shall be deemed to be an extension of the time for performance of any other obligations or any other
acts. The rights and remedies of the parties under this Securities Purchase Agreement are in addition to all other rights and
remedies, at law or equity, that they may have against each other.

 

[signature
page follows]

 

    10

     

    

 

SIGNATURE
PAGE TO SECURITIES PURCHASE AGREEMENT

 

INFORMATION
IN RESPONSE TO THIS SECTION WILL BE KEPT STRICTLY CONFIDENTIAL

 

	DOLLAR
    AMOUNT INVESTED:	$	 
	 	 	 
	NUMBER
OF WARRANTS TO BE ISSUED	 	 

 

AMOUNT
INVESTED TO BE SENT VIA: ☐ Check (enclosed) ☐ Wire

 

	Name
    in Which Note and Warrants Should Be Issued:	 

 

	Name
    of Purchaser:	 
	 	 
	Taxpayer
    ID Number:	 
	 	 
	               OR	 
	 	 
	Social
    Security Number:	 

 

Address
Information:

 

For
individual subscribers this address should be the Purchaser ’s primary legal residence. For entities other than individual
subscribers, please provide address information for the entities primary place of business. Information regarding a joint subscriber
should be included in the column at right.

 

	 	 	 
	Legal
    Address	 	Legal
    Address
	 	 	 
	 	 	 
	City,
    State, and Zip Code	 	City,
    State, and Zip Code

 

	AGREED
    AND SUBSCRIBED	 	ACCEPTED
    
	 	 	 	 	 
	This
    ___ day of _________, 2018	 	This
    ___ day of _______, 2019
	 	 	 	 	 
	By:	 	 	By:	 
	 	Name:
    	 	 	Name:
    Jeremy Frommer 
	 	Title
    (if any): 	 	 	Title:
    Chief Executive Officer

 

     

     

    

 

CERTIFICATE
OF SIGNATORY

(To
be completed if the Securities are

being
subscribed for by an entity)

 

I______________________
am the ___________________________ of ___________________________ (the “Entity”).

 

I
certify that I am empowered and duly authorized by the Entity to execute and carry out the terms of the Securities Purchase Agreement
and to purchase and hold the Notes and Warrants, and certify further that the Securities Purchase Agreement has been duly and
validly executed on behalf of the Entity and constitutes a legal and binding obligation of the Entity.

 

IN
WITNESS WHEREOF, I have set my hand this ____ day of _______________, 2019.

 

	 	 
	(Signature)	 

 

 

     

     

    

 

Schedule
3(c)

 

	 	 	Share Equivalent	 
	Convertible Notes	 	 	750,000	 
	Warrants	 	 	110,079,369	 
	Options	 	 	17,649,990	 

 

     

     

    

 

Schedule
3(m)

 

NONE

 

     

     

    

 

Schedule
3(n)

 

Jerrick
Ventures, LLC, a wholly-owned subsidiary of the Company, is the petitioner in an action captioned Jerrick Ventures, LLC
v. Pamela Weintraub, Penthouse Global Media, Inc., Penthouse World Media, LLC, and Alpha Cyni, Inc. (Cancellation No.
92,063,829), which is pending before the Trademark Trial and Appeal Board of the United States Patent and Trademark Office (the
“TTAB”).  In this case, Jerrick seeks to cancel a registration for the OMNI mark filed by Weintraub.  The
matter is currently pending before TTAB.Exhibit 10.2

 

NEITHER
THIS CONVERTIBLE PROMISSORY NOTE NOR THE SECURITIES UNDERLYING THIS CONVERTIBLE PROMISSORY NOTE, NOR ANY SECURITIES ISSUABLE UPON
ITS CONVERSION, IF ANY, HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED
UNDER APPLICABLE STATE SECURITIES LAWS AND MAY ONLY BE ACQUIRED FOR INVESTMENT PURPOSES ONLY AND NOT WITH A VIEW TO, OR IN CONNECTION
WITH, THE SALE OR DISTRIBUTION THEREOF. THIS CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES UNDERLYING THIS CONVERTIBLE PROMISSORY
NOTE, OR THE SECURITIES ISSUABLE UPON ITS CONVERSION, IF ANY, MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT AND QUALIFICATION UNDER APPLICABLE STATE LAW
WITHOUT AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION AND QUALIFICATION ARE NOT REQUIRED UNDER THE
ACT OR RECEIPT OF A NO-ACTION LETTER FROM THE SECURITIES AND EXCHANGE COMMISSION.

 

JERRICK
MEDIA HOLDINGS, INC.

 

CONVERTIBLE
PROMISSORY NOTE

 

Dated:
February    , 2019

(“Issuance
Date”)

 

FOR
VALUE RECEIVED JERRICK MEDIA HOLDINGS, INC., a company organized under the laws of Nevada (the “Company”),
hereby promises to pay to______________________________________ (the “Payee”), or its registered assigns,
the principal amount of ___________________________ ($_____________.00 USD) together with interest thereon calculated from
the Issuance Date (“Interest Commencement Date”) in accordance with the provisions of this Convertible Promissory
Note (as amended, modified and supplemented from time to time, this “Note” and together with any other Notes
issued in the Note Issuance (as defined below) or upon transfer or exchange, the “Notes”). Capitalized terms
not defined in this Note shall have the meaning ascribed to them in the Securities Purchase Agreement dated as of the date hereof.

 

Certain
capitalized terms are defined in Section 8 hereof.

 

1.
Payment of Interest. Interest shall accrue at a rate equal to ten percent (10%) per annum (the “Interest
Rate”) beginning on the Interest Commencement Date on the unpaid principal amount of this Note and shall be payable
in kind upon the twelve (12) month anniversary of the Interest Commencement Date; provided that the interest rate shall
increase five percent (5%) above the current Interest Rate (i) so long as any Event of Default has occurred and is continuing;
or (ii) in the event that the Company does not consummate a listing onto a national securities exchange on the date that is nine
(9) months from the First Closing Date, and the Note is still outstanding. In no event shall any interest to be paid under the
Notes exceed the maximum rate permitted by law. In any such event, the Note shall automatically be deemed amended to permit interest
charges at an amount equal to, but not greater than, the maximum rate permitted by law. Interest shall be computed on the basis
of the actual number of days elapsed and a 360-day year.

 

2.
Maturity Date. The entire principal amount of this Note shall be due and payable in full in cash in immediately available
funds twelve (12) months from the date of issuance (such date, the “Maturity Date”) upon the tender of such
Note by Payee. The accrued, but unpaid interest on this Note shall be due and payable in the form of the Company’s Common
Stock upon the Maturity Date at the conversion price then in effect of this Note.

 

3.
Conversion.

 

(i) 

 

(a)
Optional Conversion. The Payee shall have the option to (i) convert this Note and any accrued but unpaid interest
into shares of the Company’s Common Stock at any time during the term of the Note or (ii) upon the Maturity Date, tender
this Note to the Company for immediate repayment of principal and accrued and unpaid interest in the Company’s Common Stock.
The number of shares that shall be issuable upon conversion of the Note shall equal the lesser of (i) the number derived by
dividing (x) the principal amount of the Note plus any accrued and unpaid interest thereon by (y) US $0.25 (twenty five cents
US) or (ii) the price provided to investors in connection with the Qualified Offering.

 

     

     

    

 

(b)
Mandatory Conversion. In the event that the Payee does not choose to convert the Note into the Company’s Common Stock
on or prior to the Maturity Date, the principal and interest evidenced by the Note shall be mandatorily converted upon the earlier
of (i) the listing of the Company’s Common Stock onto a national securities exchange, or (ii) upon a Qualified Offering.
If the Qualified Offering provides the investors in the Qualified Offering with warrants or another type of equity incentive,
the Payee shall receive those warrants or equity incentives on a proportional basis to the amount the Payee converted into the
Qualified Offering. Upon the closing of the Qualified Offering, or on the day the Company begins trading on a national securities
exchange (whichever is to occur first), the outstanding principal amount of, and all accrued but unpaid interest on, this Note
will automatically be converted into the Qualified Offering at a price equal to the price provided to investors in connection
with the Qualified Offering.

 

No
fractional shares shall be issued upon a conversion. In lieu of any fractional shares to which Payee would otherwise be entitled,
the Company shall round up to the nearest whole share. Should the Qualified Offering of such securities provide for the issuance
of warrants, the Holder hereof would also be entitled to such warrant, all on the same terms and conditions and in the same form
as provided in the offering documentation governing the Qualified Offering.

 

In
order to convert this Note in to Common Stock, the Holder must deliver a dated and signed notice of conversion (the “Notice
of Conversion”), a copy of which is attached to this Note as Exhibit A, stating its intention to convert the
full principal amount of this Note into Common Stock, Notices of Conversion shall be deemed delivered on the date sent, if personally
delivered, to the Company’s Chief Executive Officer at the Company’s principal place of business, or when actually
received if sent by another method. The Notice of Conversion shall be accompanied by the original Note.

 

(ii)  As
soon as possible after the conversion has been effected (but in any event within two (2) Business Days), the Company or acquirer
shall deliver to the converting holder a certificate or certificates representing the Common Stock issuable by reason of such
conversion in such name or names and such denomination or denominations as the converting holder has specified. In the event that
the Payee elects to tender this Note to the Company for immediate repayment, such payment shall be delivered to the Payee within
five (5) business days to the address provided by the Payee to the Company at the time of the surrender of this Note.

 

(iii)  The
issuance of Common Stock upon conversion of this Note shall be made without charge to the holder hereof in respect thereof or
other cost incurred by the Company or acquirer in connection with such conversion. Upon conversion of this Note, the Company shall
take all such actions as are necessary in order to ensure that the Company’s Common Stock issuable upon conversion of the
Note shall be validly issued, fully paid and nonassessable.

 

(iv)  Neither
the Company nor acquirer shall close its books against the transfer of this Note in any manner which interferes with the timely
conversion of this Note. The Company shall assist and cooperate with any holder of this Note required to make any governmental
filings or obtain any governmental approval prior to or in connection with the conversion of this Note (including, without limitation,
making any filings required to be made by the Company).

 

(v)  The
Company shall at all times reserve and keep available out of its authorized but unissued shares of Common Stock, solely for the
purpose of issuance upon conversion hereunder, such number of shares of Common Stock issuable upon conversion. All shares of such
capital stock which are so issuable shall, when issued, be duly and validly issued, fully paid and non-assessable and free from
all taxes, liens and charges. The Company shall take all such actions as may be necessary to assure that all such shares of capital
stock may be so issued without violation of any applicable law or governmental regulation or any requirements of any domestic
securities exchange upon which such shares of capital stock.

 

4.
Prepayment. The principal amount of this Note may be prepaid, in whole or in part, at any time from the date of issuance
at the option of the Company, together with Interest accrued to the date of prepayment. Any such prepayment shall be made pro
rata based on such Payee’s share of the aggregate principal amount then owed by the Company to all of the Payees under all
the Notes.

 

    2

     

    

 

5.
Method of Payments.

 

(i)  Payment.
So long as the Payee or any of its nominees shall be the holder of any Note, and notwithstanding anything contained elsewhere
in this Note to the contrary, the Company will pay all sums for principal, interest, or otherwise becoming due on this Note held
by the Payee or such nominee not later than 1:00 p.m. New York time, on the date such payment is due, in immediately available
funds, in accordance with the payment instructions that the Payee may designate in writing, without the presentation or surrender
of such Note or the making of any notation thereon. Any payment made after 1:00 p.m. New York time, on a Business Day will be
deemed made on the next following Business Day. If the due date of any payment in respect of this Note would otherwise fall on
a day that is not a Business Day, such due date shall be extended to the next succeeding Business Day, and interest shall be payable
on any principal so extended for the period of such extension. All amounts payable under this Note shall be paid free and clear
of, and without reduction by reason of, any deduction, set-off or counterclaim. The Company will afford the benefits of this Section
to the Payee and to each other Person holding this Note.

 

(ii)  Transfer
and Exchange. Upon surrender of any Note for registration of transfer or for exchange to the Company, in accordance with the
terms hereof, at its principal office, the Company at its sole expense will execute and deliver in exchange therefor a new Note
or Notes, as the case may be, as requested by the holder or transferee, which aggregate principal amount is equal the unpaid principal
amount of such Note, registered as such holder or transferee may request, dated so that there will be no loss of interest on the
Note and otherwise of like tenor; provided that this Note may not be transferred by Payee to any Person other than Payee’s
affiliates without the prior written consent of the Company (which consent shall not be unreasonably withheld or delayed). The
issuance of new Notes shall be made without charge to the holder(s) of the surrendered Note for any issuance tax in respect thereof
or other cost incurred by the Company in connection with such issuance, provided that each Noteholder shall pay any transfer taxes
associated therewith. The Company shall be entitled to regard the registered holder of this Note as the holder of the Note so
registered for all purposes until the Company or its agent, as applicable, is required to record a transfer of this Note on its
register.

 

(iii)  Replacement.
Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of any Note and,
in the case of any such loss, theft or destruction of any Note, upon receipt of an indemnity reasonably satisfactory to the Company
or, in the case of any such mutilation, upon the surrender and cancellation of such Note, the Company, at its expense, will execute
and deliver, in lieu thereof, a new Note of like tenor and dated the date of such lost, stolen, destroyed or mutilated Note.

 

6.  Covenants
of the Company. The Company covenants and agrees as follows:

 

(i)  Consolidation,
Merger and Sale. With the exception of a reverse merger transaction, the Company will not sell or otherwise dispose of (or
permit any subsidiary to sell or otherwise dispose of) a material portion of its property or assets in one or more transactions
for so long as any of the Notes remain outstanding.

 

(ii)  Use
of Proceeds. The Company shall use the proceeds for general working capital purposes and will have broad discretion with respect
to the allocation of these funds.

 

7.  Events
of Default. If any of the following events take place before or on the Maturity Date (each, an “Event of Default”),
Payee at its option may declare all principal and accrued and unpaid interest thereon and all other amounts payable under this
Note immediately due and payable; provided, however, that this Note shall automatically become due and payable without
any declaration in the case of an Event of Default specified in clause (iii) or (v), below:

 

	 	(i)	Company
    fails to make payment of the full amount due under this Note upon the tender of such Note following the Maturity Date; or

 

	 	(ii)	A
    receiver, liquidator or trustee of Company or any substantial part of Company’s assets or properties is appointed by
    a court order; or

 

    3

     

    

 

	 	(iii)	Company
    is adjudicated bankrupt or insolvent; or

 

	 	(iv)	Any
    of Company’s property is sequestered by or in consequence of a court order and such order remains in effect for more
    than 30 days; or

 

	 	(v)	Company
    files a petition in voluntary bankruptcy or requests reorganization under any provision of any bankruptcy, reorganization
    or insolvency law or consents to the filing of any petition against it under such law, or

 

	 	(vi)	Proceedings
    for the appointment of a receiver, trustee or custodian of the Company or of all or a substantial part of the assets or property
    thereof, or an involuntary case or other proceedings seeking liquidation, reorganization or other relief with respect to the
    Company or the debts thereof under any bankruptcy, insolvency or other similar law now or hereafter in effect shall be commenced
    and an order for relief entered or such proceeding shall not be dismissed or discharged within sixty (60) days of commencement.

 

	 	(vii)	Company
    makes a formal or informal general assignment for the benefit of its creditors, or admits in writing its inability to pay
    debts generally when they become due, or consents to the appointment of a receiver or liquidator of Company or of all or any
    part of its property; or

 

	 	(viii)	An
    attachment or execution is levied against any substantial part of Company’s assets that is not released within 30 days;
    or

 

	 	(ix)	Company
    dissolves, liquidates or ceases business activity, or transfers any major portion of its assets other than in the ordinary
    course of business; provided that this paragraph (ix) shall not apply to any contemplated real estate transaction; or

 

	 	(x)	Company
    breaches any covenant or agreement on its part contained in this Note or the Securities Purchase Agreement and does not cure
    such breach within 10 Business Days; or

 

	 	(xi)	Any
    material inaccuracy or untruthfulness of any representation or warranty of the Company set forth in this Note, the Securities
    Purchase Agreement or other offering documents, schedules and exhibits related thereto.

 

8.  Definitions.

 

“Business
Day” means a day (other than a Saturday or Sunday) on which banks generally are open in New York, New York for the conduct
of substantially all of their activities.

 

“Noteholder”
or “Payee” with respect to any Note, means at any time each Person then the record owner hereof and “Noteholders”
or “Payees” means all of such Noteholders or Payees, collectively.

 

“Note
Issuance” or “Offering” shall mean the Convertible Promissory Notes issued by the Company to the
Payee and other Noteholders (each in substantially the form of this Note) in the original principal amount not to exceed $2,500,000
in the aggregate.

 

“Person”
means any person or entity of any nature whatsoever, specifically including an individual, a firm, a company, a corporation, a
partnership, a limited liability company, a trust or other entity.

 

“Qualified
Offering” means not including the Second Closing of this Offering (i) any private placement offerings or one or more
registered public offerings by the Company under the Securities Act, pursuant to which the Company receives monies in the amount
greater than $1,500,000 in exchange for securities of the Company between the First Closing Date and the date on which the Company’s
consummates a listing onto a national securities exchange, or (ii) any private placement offerings or one or more registered public
offerings by the Company under the Securities Act in connection with its listing onto a national securities exchange.

 

    4

     

    

 

“Securities
Purchase Agreement” means the Securities Purchase Agreement, dated February ___, 2019 between the Company and the Payee.

  

9.  Expenses
of Enforcement, etc. The Company agrees to pay all reasonable fees and expenses incurred by the Payee in connection with any
amendments, modifications, waivers, extensions, renewals, renegotiations or “workouts” of the provisions hereof or
incurred by the Payee in connection with the enforcement or protection of its rights in connection with this Note, or in connection
with any pending or threatened action, proceeding, or investigation relating to the foregoing, including but not limited to the
reasonable fees and disbursements of counsel for the Payee. The Company indemnifies the Payee and its directors, managers, affiliates,
partners, members, officers, employees and agents against, and agrees to hold the Payee and each such person and/or entity harmless
from, any and all losses, claims, damages, liabilities and related expenses, including reasonable counsel fees and expenses, incurred
by or asserted against the Payee or any such person and/or entity arising out of, in any way connected with, or as a result of
(i) the consummation of the loan evidenced by this Note and the use of the proceeds thereof or (ii) any claim, litigation, investigation
or proceedings relating to any of the foregoing, whether or not the Payee or any such person and/or entity is a party thereto
other than any loss, claim, damage, liability or related expense incurred or asserted against the payee or any such person on
account of the payee’s or such person’s gross negligence or willful misconduct. Notwithstanding the foregoing, with
respect to the indemnification obligations of the Company hereunder, (i) the Company’s aggregate liability under this Note
to the Payee shall not exceed the aggregate principal amount of the Note and all accrued and unpaid interest thereon and (ii)
indemnified liabilities shall not include any liability of any indemnitee arising out of such indemnitee’s gross negligence.
To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum
contribution to the payment and satisfaction of each of the indemnified liabilities which is permissible under applicable law.

 

10.  Amendment
and Waiver. The provisions of this Note may not be modified, amended or waived, and the Company may not take any action herein
prohibited, or omit to perform any act herein required to be performed by it, without the written consent of the holder.

 

11.  Remedies
Cumulative. No remedy herein conferred upon the Payee is intended to be exclusive of any other remedy and each and every such
remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law
or in equity or by statute or otherwise.

 

12.  Remedies
Not Waived. No course of dealing between the Company and the Payee or any delay on the part of the Payee in exercising any
rights hereunder shall operate as a waiver of any right of the Payee.

 

13.  Assignments.
The Payee may assign, participate, transfer or otherwise convey this Note and any of its rights or obligations hereunder or interest
herein to any affiliate of Payee and to any other Person that the Company consents to (such consent not to be unreasonably withheld
or delayed), and this Note shall inure to the benefit of the Payee’s successors and assigns. The Company shall not assign
or delegate this Note or any of its liabilities or obligations hereunder.

 

14.  Headings.
The headings of the sections and paragraphs of this Note are inserted for convenience only and do not constitute a part of this
Note.

 

15.  Severability.
If any provision of this Note is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of
this Note will remain in full force and effect. Any provision of this Note held invalid or unenforceable only in part or degree
will remain in full force and effect to the extent not held invalid or unenforceable.

 

16.  Cancellation.
After all principal, premiums (if any) and accrued interest at any time owed on this Note have been paid in full, or this Note
has been converted this Note will be surrendered to the Company for cancellation and will not be reissued.

 

17.  Maximum
Legal Rate. If at any time an interest rate applicable hereunder exceeds the maximum rate permitted by law, such rate shall
be reduced to the maximum rate so permitted by law.

 

    5

     

    

 

18.  Place
of Payment and Notices. Unless otherwise stated herein, payments of principal and interest are to be delivered to the Noteholder
of this Note at the address provided by the Payee in the Note Securities Purchase Agreement, or at such other address as such
Noteholder has specified by prior written notice to the Company. No notice shall be deemed to have been delivered until the first
Business Day following actual receipt thereof at the foregoing address.

 

19.  Waiver
of Jury Trial. The Payee and the Company each hereby waives any right it may have to a trial by jury in respect of any litigation
directly or indirectly arising out of, under or in connection with this Note and/or the transactions contemplated hereunder.

 

20.  Submission
to Jurisdiction.

 

(i)  Any
legal action or proceeding with respect to this Note may be brought in the courts of the State of New Jersey or of the United
States of America sitting in New Jersey, and, by execution and delivery of this Note, the Company hereby accepts for itself and
in respect of its property, generally and unconditionally, the jurisdiction of the aforesaid courts.

 

(ii)  The
Company hereby irrevocably waives, in connection with any such action or proceeding, any objection, including, without limitation,
any objection to the laying of venue or based on the grounds of forum non conveniens, which they may now or hereafter have to
the bringing of any such action or proceeding in such respective jurisdictions.

 

(iii)  Nothing
herein shall affect the right of the Payee to serve process in any other manner permitted by law or to commence legal proceedings
or otherwise proceed against the Company in any other jurisdiction.

 

21.  GOVERNING
LAW. ALL ISSUES AND QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS NOTE SHALL BE
GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW JERSEY, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW
OR CONFLICT OF LAW RULES OR PROVISIONS (WHETHER OF THE STATE OF NEW JERSEY OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE APPLICATION
OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF NEW JERSEY.

  

**********************************************

  

    6

     

    

 

IN
WITNESS WHEREOF, the Company has executed and delivered this Convertible Promissory Note on the date first written above.

 

	 	COMPANY:
	 	 
	 	JERRICK
    MEDIA HOLDINGS, INC.
	 	 	 
	 	By:	 
	 	 	Jeremy
    Frommer
	 	 	Chief
    Executive Officer

 

    7

     

    

 

EXHIBIT
A 

 

NOTICE
OF CONVERSION

 

(To
Be Signed Only Upon Conversion of the Convertible Promissory Note)

 

The
undersigned, the holder of the foregoing Convertible Promissory Note, hereby surrenders such Note for conversion into shares of
Common Stock of Jerrick Media Holdings, Inc. to the extent of $ _________unpaid principal amount and any accrued and unpaid
interest of such Note, and requests that the certificates for such shares be issued in the name of, and delivered to:

 

	 	Name:	 
	 	 	 
	 	Address	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

Dated:
__/__/ 20__

 

	 	 
	 	(Signature
    must conform in all respects to name of holder as specified on the face of the Debenture)
	 	 
	 	 
	 	(Address)

 

 

A-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}]]